Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000639498 | SCV000761073 | likely benign | Familial hypocalciuric hypercalcemia; Autosomal dominant hypocalcemia 1 | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002257885 | SCV002531536 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-01 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002492996 | SCV002802880 | likely benign | Familial hypocalciuric hypercalcemia 1; Neonatal severe primary hyperparathyroidism; Epilepsy, idiopathic generalized, susceptibility to, 8; Autosomal dominant hypocalcemia 1 | 2021-11-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004025582 | SCV005035285 | likely benign | Nephrolithiasis/nephrocalcinosis | 2023-10-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |